Sensus Healthcare, Inc. (NASDAQ:SRTS) Sees Large Growth in Short Interest

Sensus Healthcare, Inc. (NASDAQ:SRTS) was the target of a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 583,500 shares, an increase of 20.0% from the November 30th total of 486,100 shares. Based on an average trading volume of 174,600 shares, the days-to-cover ratio is currently 3.3 days. Currently, 4.4% of the shares of the stock are sold short.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. Maxim Group increased their price objective on Sensus Healthcare from $12.00 to $14.00 and gave the stock a “buy” rating in a research note on Friday, November 15th. HC Wainwright lifted their price target on shares of Sensus Healthcare from $10.00 to $11.00 and gave the company a “buy” rating in a report on Monday, November 18th.

Hedge Funds Weigh In On Sensus Healthcare

Several large investors have recently made changes to their positions in the company. Acadian Asset Management LLC increased its holdings in Sensus Healthcare by 578.6% in the second quarter. Acadian Asset Management LLC now owns 45,124 shares of the company’s stock valued at $239,000 after purchasing an additional 38,474 shares during the last quarter. Sachetta LLC increased its position in shares of Sensus Healthcare by 12.9% in the second quarter. Sachetta LLC now owns 118,354 shares of the company’s stock valued at $631,000 after acquiring an additional 13,544 shares during the last quarter. Dimensional Fund Advisors LP raised its holdings in Sensus Healthcare by 128.0% during the second quarter. Dimensional Fund Advisors LP now owns 166,590 shares of the company’s stock worth $888,000 after acquiring an additional 93,511 shares in the last quarter. Renaissance Technologies LLC grew its stake in Sensus Healthcare by 34.4% in the second quarter. Renaissance Technologies LLC now owns 391,534 shares of the company’s stock valued at $2,087,000 after purchasing an additional 100,294 shares in the last quarter. Finally, XTX Topco Ltd acquired a new position in shares of Sensus Healthcare during the 2nd quarter worth approximately $95,000. Institutional investors and hedge funds own 25.30% of the company’s stock.

Sensus Healthcare Stock Performance

Sensus Healthcare stock traded down $0.30 on Tuesday, reaching $6.87. The company’s stock had a trading volume of 195,104 shares, compared to its average volume of 273,232. The business’s fifty day moving average price is $7.62 and its 200 day moving average price is $6.58. The company has a market cap of $112.59 million, a price-to-earnings ratio of 12.05 and a beta of 1.16. Sensus Healthcare has a twelve month low of $2.36 and a twelve month high of $9.33.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.